HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of NAADP signalling on reperfusion protects the heart by preventing lethal calcium oscillations via two-pore channel 1 and opening of the mitochondrial permeability transition pore.

AbstractAIMS:
In the heart, a period of ischaemia followed by reperfusion evokes powerful cytosolic Ca(2+) oscillations that can cause lethal cell injury. These signals represent attractive cardioprotective targets, but the underlying mechanisms of genesis are ill-defined. Here, we investigated the role of the second messenger nicotinic acid adenine dinucleotide phosphate (NAADP), which is known in several cell types to induce Ca(2+) oscillations that initiate from acidic stores such as lysosomes, likely via two-pore channels (TPCs, TPC1 and 2).
METHODS AND RESULTS:
An NAADP antagonist called Ned-K was developed by rational design based on a previously existing scaffold. Ned-K suppressed Ca(2+) oscillations and dramatically protected cardiomyocytes from cell death in vitro after ischaemia and reoxygenation, preventing opening of the mitochondrial permeability transition pore. Ned-K profoundly decreased infarct size in mice in vivo. Transgenic mice lacking the endo-lysosomal TPC1 were also protected from injury.
CONCLUSION:
NAADP signalling plays a major role in reperfusion-induced cell death and represents a potent pathway for protection against reperfusion injury.
AuthorsSean M Davidson, Kirsty Foote, Suma Kunuthur, Raj Gosain, Noah Tan, Richard Tyser, Yong Juan Zhao, Richard Graeff, A Ganesan, Michael R Duchen, Sandip Patel, Derek M Yellon
JournalCardiovascular research (Cardiovasc Res) Vol. 108 Issue 3 Pg. 357-66 (Dec 01 2015) ISSN: 1755-3245 [Electronic] England
PMID26395965 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology.
Chemical References
  • 1-(3-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido(3,4-b)indole-3-carboxylic acid
  • Calcium Channels
  • Carbolines
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Ned-K compound
  • Piperazines
  • TPCN1 protein, mouse
  • NADP
  • NAADP
Topics
  • Animals
  • Calcium Channels (deficiency, genetics, metabolism)
  • Calcium Signaling (drug effects)
  • Carbolines (pharmacology)
  • Cytoprotection
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mitochondria, Heart (drug effects, metabolism, pathology)
  • Mitochondrial Membrane Transport Proteins (antagonists & inhibitors, metabolism)
  • Mitochondrial Permeability Transition Pore
  • Mitochondrial Swelling (drug effects)
  • Myocardial Infarction (genetics, metabolism, pathology, prevention & control)
  • Myocardial Reperfusion Injury (genetics, metabolism, pathology, prevention & control)
  • Myocytes, Cardiac (drug effects, metabolism, pathology)
  • NADP (analogs & derivatives, antagonists & inhibitors, metabolism)
  • Piperazines (pharmacology)
  • Rats, Sprague-Dawley
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: